US Stock MarketDetailed Quotes

ALLK Allakos

Watchlist
  • 0.877
  • -0.030-3.34%
Close Nov 22 16:00 ET
  • 0.959
  • +0.082+9.40%
Post 20:01 ET
78.32MMarket Cap-431P/E (TTM)

About Allakos Company

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.

Company Profile

SymbolALLK
Company NameAllakos
Listing DateJul 19, 2018
Issue Price18.00
Founded2012
CEODr. Robert Alexander, PhD
MarketNASDAQ
Employees131
Fiscal Year Ends12-31
Address825 Industrial Road,Suite 500
CitySan Carlos
ProvinceCalifornia
CountryUnited States of America
Zip Code94070
Phone1-650-597-5002
Websitehttp://www.allakos.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert Alexander, PhD
  • Director and Chief Executive Officer
  • 6.30M
  • H. Baird Radford,III
  • Chief Financial Officer and Principal Accounting Officer
  • 2.74M
  • Dr. Chin Lee, M.D.,M.P.H.
  • Chief Medical Officer
  • --
  • Daniel S. Janney
  • Chairman of the Board
  • 434.62K
  • Dr. Adam Tomasi, PhD
  • President
  • 4.27M
  • Steven P. James
  • Independent Director
  • 387.12K
  • Dr. Neil Graham, M.B.B.S.,M.D.,M.P.H.
  • Independent Director
  • 378.28K
  • Dr. Everett Rand Sutherland, M.D.
  • Independent Director
  • 732.48K
  • Robert E. Andreatta
  • Independent Director
  • 389.62K
  • Dr. Dolca Thomas, M.D.
  • Independent Director
  • 732.48K
  • Paul Walker
  • Independent Director
  • 387.12K
  • Dr. Amy L. Ladd, M.D.
  • Independent Director
  • 372.12K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data